Adicet Bio, Inc

Add to watchlist
€10.0
Last updated:06/10/2021
1IJA: F
Adicet Bio, Inc

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor ta… Show more

P/E ratio
-

Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
Company results
Quarterly
Annual
Fundamentals
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
-9.299M
-28.138M
-202.59%
-36.678M
-30.35%
Cashflow
Sum up money going in and out company
-18.18M
-27.882M
-53.37%
-41.552M
-49.03%
Total liabilities
All combined debts and obligations
-
141.953M
+Infinity%
44.008M
-69.00%
Company profile
CEO
Mr. Chen Schor CPA, M.B.A., MBA, CPA, BA
Market capitalization
Small (0.33B)